Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. AMENDMENT NO. 3 TO AGREEMENTAgreement • February 27th, 2008 • Idexx Laboratories Inc /De • In vitro & in vivo diagnostic substances
THIS AMENDMENT NO. 3 TO AGREEMENT (this “Amendment”) is made effective as of the 18th day of January, 2008, between IDEXX Operations, Inc., a Delaware corporation whose principal place of business is at 6100 East Shelby Drive, Memphis, Tennessee 38141, U.S.A. (“IDEXX”) and Ortho-Clinical Diagnostics, Inc., a New York corporation with offices at 100 Indigo Creek Drive, Rochester, New York, U.S.A. (“OCD”).
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. AMENDMENT NO. 2 TO AGREEMENTAmendment No. 2 to Agreement • February 27th, 2008 • Idexx Laboratories Inc /De • In vitro & in vivo diagnostic substances
THIS AMENDMENT NO. 2 TO AGREEMENT (this “Amendment”) is made effective as of the 18th day of January, 2008, between IDEXX Europe B.V., a company organized under the law of The Netherlands whose principal place of business is at Koolhovenlaan 20, 1119 NE - Schiphol-Rijk, The Netherlands (“IDEXX”) and Ortho-Clinical Diagnostics, Inc., a New York corporation with offices at 100 Indigo Creek Drive, Rochester, New York, U.S.A. (“OCD”).
AMENDMENT NO. 2 TO AGREEMENTAgreement • February 27th, 2008 • Idexx Laboratories Inc /De • In vitro & in vivo diagnostic substances
THIS AMENDMENT NO. 2 TO AGREEMENT (this “Amendment”) is made effective as of the 15th day of October, 2006, between IDEXX Operations, Inc., a Delaware corporation whose principal place of business is at 6100 East Shelby Drive, Memphis, Tennessee 38141, U.S.A. (“IDEXX”) and Ortho-Clinical Diagnostics, Inc., a New York corporation with offices at 100 Indigo Creek Drive, Rochester, New York, U.S.A. (“OCD”).
